1. Home
  2. MOLN vs HURC Comparison

MOLN vs HURC Comparison

Compare MOLN & HURC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOLN
  • HURC
  • Stock Information
  • Founded
  • MOLN 2004
  • HURC 1968
  • Country
  • MOLN Switzerland
  • HURC United States
  • Employees
  • MOLN N/A
  • HURC N/A
  • Industry
  • MOLN
  • HURC Industrial Machinery/Components
  • Sector
  • MOLN
  • HURC Industrials
  • Exchange
  • MOLN Nasdaq
  • HURC Nasdaq
  • Market Cap
  • MOLN 142.6M
  • HURC 125.1M
  • IPO Year
  • MOLN 2021
  • HURC N/A
  • Fundamental
  • Price
  • MOLN $3.75
  • HURC $17.55
  • Analyst Decision
  • MOLN Hold
  • HURC
  • Analyst Count
  • MOLN 1
  • HURC 0
  • Target Price
  • MOLN $4.00
  • HURC N/A
  • AVG Volume (30 Days)
  • MOLN 5.2K
  • HURC 34.2K
  • Earning Date
  • MOLN 11-05-2025
  • HURC 09-05-2025
  • Dividend Yield
  • MOLN N/A
  • HURC N/A
  • EPS Growth
  • MOLN N/A
  • HURC N/A
  • EPS
  • MOLN N/A
  • HURC N/A
  • Revenue
  • MOLN $856,302.00
  • HURC $186,789,000.00
  • Revenue This Year
  • MOLN N/A
  • HURC N/A
  • Revenue Next Year
  • MOLN $1,000.00
  • HURC N/A
  • P/E Ratio
  • MOLN N/A
  • HURC N/A
  • Revenue Growth
  • MOLN N/A
  • HURC N/A
  • 52 Week Low
  • MOLN $3.36
  • HURC $13.19
  • 52 Week High
  • MOLN $7.60
  • HURC $23.76
  • Technical
  • Relative Strength Index (RSI)
  • MOLN 51.77
  • HURC 46.89
  • Support Level
  • MOLN $3.69
  • HURC $17.19
  • Resistance Level
  • MOLN $3.85
  • HURC $18.43
  • Average True Range (ATR)
  • MOLN 0.15
  • HURC 0.92
  • MACD
  • MOLN 0.01
  • HURC 0.06
  • Stochastic Oscillator
  • MOLN 37.27
  • HURC 50.88

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About HURC Hurco Companies Inc.

Hurco Companies Inc is a United States-based industrial technology company. It designs, manufactures, and sells computerized machine tools, consisting mainly of vertical machining centers and turning centers, to companies in the metalworking industry through sales, service, and distribution networks. The company concentrated on designing user-friendly computer control systems that both skilled and unskilled machine tool operators can operate. It generates maximum revenue from the Computerized Machine Tools product. Geographically, It derives a majority of its revenue from the United States of America. Its product categories include 5-Axis VMC; 3-Axis VMC; Horizontal MC and Turning Centers.

Share on Social Networks: